An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D)
ConclusionsIncluding anti-obesity medication was associated with superior weight loss with noninferior HbA1c reductions, warranting further evaluation in larger study populations of obesity-focused approaches to type 2 diabetes management.Graphical abstract available for this article.Trial RegistrationClinicalTrials.gov NCT03799198.Graphical Abstract
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: COVID-19 | Diabetes | Eating Disorders & Weight Management | Endocrinology | Obesity | Study | Weight Loss